-
VCRE share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of VCRE shares has decreased $0.05 since the market last closed. This is a 0.48% drop.
-
Last closed at $10.35.
The stock has since dropped $0.32 in pre-market trading.
Key terms
About VCRE
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
-
Market cap: $2.84B
A market capitalization between $2 billion and $10 billion places VCRE in the mid-capitalization category.
Key terms
Smart score
Latest VCRE news
No recent press releases are available for VCRE
VCRE Financials
-
Total revenue: $389.19K (1Y), $236.32K (Q2)
Total Revenue decreased 96.24% since last year and increased 258.83% since last quarter.
-
Net income: -$48.68M (1Y), -$15.25M (Q2)
Net Income decreased 205.23% since last year and decreased 28.37% since last quarter.
-
Earnings per share: -$2.03 (1Y), -$0.54 (Q2)
EPS decreased 74.13% since last year and decreased 28.36% since last quarter.
Key terms
VCRE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VCRE Competitors
-
How competitors are chosen
VCRE's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
-
Market cap: $2.84B
A market capitalization between $2 billion and $10 billion places VCRE in the mid-capitalization category.
